| Value | ₹22,665 Cr |
|---|
BSE filing, NSE: IOB. Summary written from the filing by ALFA Finder's alert engine.
Indian Overseas Bank: key numbers
- Share price
- ₹29.25
- Market cap
- ₹56,326 Cr
- Revenue (annual)
- ₹31,896 Cr
- Net profit (annual)
- ₹5,418 Cr
- P/E (TTM)
- 8.4×Sector 19.1×
- Promoter holding
- 92.44%+0.00% QoQ
- FII holding
- 0.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indian Overseas Bank
All →Indian Overseas Bank Management Change
Indian Overseas Bank's board appointed Mr. Akshit Choudhary as Chief Financial Officer effective 1 November 2026, replacing Mr. Madhaw Chandra Jha. The filing includes his brief profile and the required LODR disclosures.
Indian Overseas Bank Investor Presentation: Key Takeaways
Q2 FY27 net profit Rs1,912 Cr, up 55.95% YoY and 15.25% QoQ. NII Rs3,867 Cr (+26.41% YoY). ROE 24.58%, ROA 1.53%, GNPA 1.19%.
Indian Overseas Bank Results Update
IOB's net profit jumped 55.95% YoY to ₹1,912 Crore in Q2 FY27, with operating profit rising 25.67% to ₹3,016 Crore. NII grew 26.41% and NPA ratios continued to improve.
Indian Overseas Bank Q2 FY27 Results: Net Profit ₹1,963 Cr, Up 55.9% YoY
Indian Overseas Bank reported revenue from operations of ₹9,201 Cr (+17.2% YoY) and net profit of ₹1,963 Cr (+55.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,963 Cr · +55.9% YoY
Indian Overseas Bank Business Update
Indian Overseas Bank disclosed RBI findings on understated risk weights for some exposures. It states no net profit impact, with CRAR remaining well above minimums.
Indian Overseas Bank Other Announcement
The filing presents the shareholding pattern of Indian Overseas Bank for the quarter ended September 30, 2026. No material transaction is reported.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.